Ogunseinde BA et al. |
A case of tacrolimus (FK506)-induced pancreatitis and fatality 2 years postcadaveric renal transplant. |
2003 |
Transplantation |
pmid:12883222
|
Keenan RJ et al. |
Immunosuppressive properties of thalidomide. Inhibition of in vitro lymphocyte proliferation alone and in combination with cyclosporine or FK506. |
1991 |
Transplantation |
pmid:1719668
|
Vathsala A et al. |
Analysis of the interactions of immunosuppressive drugs with cyclosporine in inhibiting DNA proliferation. |
1990 |
Transplantation |
pmid:1689520
|
Adams PS et al. |
Postoperative cardiac tamponade after kidney transplantation: a possible consequence of alemtuzumab-induced cytokine release syndrome. |
2013 |
Transplantation |
pmid:23380870
|
Fridell JA et al. |
Steroid withdrawal for pancreas after kidney transplantation in recipients on maintenance prednisone immunosuppression. |
2006 |
Transplantation |
pmid:16906038
|
Hostettler KE et al. |
Cyclosporine A mediates fibroproliferation through epithelial cells. |
2004 |
Transplantation |
pmid:15223908
|
Yang CW et al. |
Preconditioning with cyclosporine A or FK506 differentially regulates mitogen-activated protein kinase expression in rat kidneys with ischemia/reperfusion injury. |
2003 |
Transplantation |
pmid:12544865
|
Lykavieris P et al. |
Angioedema in pediatric liver transplant recipients under tacrolimus immunosuppression. |
2003 |
Transplantation |
pmid:12544888
|
Kiuchi T et al. |
A hepatic graft tuberculosis transmitted from a living-related donor. |
1997 |
Transplantation |
pmid:9089234
|
Donnadieu B et al. |
Central retinal vein occlusion-associated tacrolimus after liver transplantation. |
2014 |
Transplantation |
pmid:25955343
|
Loucaidou M et al. |
Five-year results of kidney transplantation under tacrolimus-based regimes: the persisting significance of vascular rejection. |
2003 |
Transplantation |
pmid:14557763
|
King-Biggs MB et al. |
Airway anastomotic dehiscence associated with use of sirolimus immediately after lung transplantation. |
2003 |
Transplantation |
pmid:12792493
|
Welberry Smith MP et al. |
Alemtuzumab induction in renal transplantation permits safe steroid avoidance with tacrolimus monotherapy: a randomized controlled trial. |
2013 |
Transplantation |
pmid:24056618
|
Barth RN et al. |
Prolonged survival of composite facial allografts in non-human primates associated with posttransplant lymphoproliferative disorder. |
2009 |
Transplantation |
pmid:19996923
|
Ciancio G et al. |
Randomized trial of dual antibody induction therapy with steroid avoidance in renal transplantation. |
2011 |
Transplantation |
pmid:22027927
|
Thervet E et al. |
Impact of cytochrome p450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients. |
2003 |
Transplantation |
pmid:14578760
|
Tabasco-Minguillan J et al. |
Insulin requirements after liver transplantation and FK-506 immunosuppression. |
1993 |
Transplantation |
pmid:7692637
|
Jain A et al. |
Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation. |
2000 |
Transplantation |
pmid:10972220
|
Wang SC et al. |
A dual mechanism of immunosuppression by FK-506. Differential suppression of IL-4 and IL-10 levels in T helper 2 cells. |
1993 |
Transplantation |
pmid:7692640
|
Zhao WY et al. |
Single kidneys transplanted from small pediatric donors less than 15 kilograms into pediatric recipients. |
2014 |
Transplantation |
pmid:25955345
|
Prud'homme GJ et al. |
GABA protects human islet cells against the deleterious effects of immunosuppressive drugs and exerts immunoinhibitory effects alone. |
2013 |
Transplantation |
pmid:23851932
|
Coto E and Tavira B |
Pharmacogenetics of calcineurin inhibitors in renal transplantation. |
2009 |
Transplantation |
pmid:19667964
|
Nobori S et al. |
Long-term acceptance of fully allogeneic cardiac grafts by cotransplantation of vascularized thymus in miniature swine. |
2006 |
Transplantation |
pmid:16421473
|
Yu S et al. |
Influence of CYP3A5 gene polymorphisms of donor rather than recipient to tacrolimus individual dose requirement in liver transplantation. |
2006 |
Transplantation |
pmid:16421475
|
Gruber SA et al. |
Initial results of solitary pancreas transplants performed without regard to donor/recipient HLA mismatching. |
2000 |
Transplantation |
pmid:10933170
|
Shapiro R et al. |
Alopecia as a consequence of tacrolimus therapy. |
1998 |
Transplantation |
pmid:9603186
|
Fernandez LA et al. |
The effects of maintenance doses of FK506 versus cyclosporin A on glucose and lipid metabolism after orthotopic liver transplantation. |
1999 |
Transplantation |
pmid:10589951
|
Batten P et al. |
Human T cell responses to human and porcine endothelial cells are highly sensitive to cyclosporin A and FK506 in vitro. |
1999 |
Transplantation |
pmid:10589954
|
Mestres J et al. |
Late subcapsular lymphocele in a kidney graft. |
2012 |
Transplantation |
pmid:22487814
|
Porrini E et al. |
Prediabetes in patients receiving tacrolimus in the first year after kidney transplantation: a prospective and multicenter study. |
2008 |
Transplantation |
pmid:18431233
|
Singla AK et al. |
Cerulomycin Caerulomycin [corrected] A: a potent novel immunosuppressive agent. |
2014 |
Transplantation |
pmid:24949498
|
Walsh C et al. |
Anti-CD25 monoclonal antibody replacement therapy for chronic kidney disease in liver transplant recipients. |
2013 |
Transplantation |
pmid:23296149
|
Kessler L et al. |
Tacrolimus-associated optic neuropathy after pancreatic islet transplantation using a sirolimus/tacrolimus immunosuppressive regimen. |
2006 |
Transplantation |
pmid:16495816
|
Podesser BK et al. |
Comparison of low and high initial tacrolimus dosing in primary heart transplant recipients: a prospective European multicenter study. |
2005 |
Transplantation |
pmid:15714171
|
Shaefer MS et al. |
Falsely elevated FK-506 levels caused by sampling through central venous catheters. |
1993 |
Transplantation |
pmid:7689264
|
Borni-Duval C et al. |
Risk factors for BK virus infection in the era of therapeutic drug monitoring. |
2013 |
Transplantation |
pmid:23778568
|
Mourer JS et al. |
Late calcineurin inhibitor withdrawal prevents progressive left ventricular diastolic dysfunction in renal transplant recipients. |
2012 |
Transplantation |
pmid:22955227
|
Danziger-Isakov LA et al. |
The risk, prevention, and outcome of cytomegalovirus after pediatric lung transplantation. |
2009 |
Transplantation |
pmid:19461492
|
Ferdman RM et al. |
Rapid intravenous desensitization to antithymocyte globulin in a patient with aplastic anemia. |
2004 |
Transplantation |
pmid:14743005
|
Gibson SW et al. |
Nutritional immunomodulation leads to enhanced allograft survival in combination with cyclosporine A and rapamycin, but not FK506. |
2000 |
Transplantation |
pmid:10852592
|
Pirenne J et al. |
Combined transplantation of small and large bowel. FK506 versus cyclosporine A in a porcine model. |
1996 |
Transplantation |
pmid:8685944
|
Burke GW et al. |
Use of FK 506 in simultaneous pancreas/kidney transplantation: lack of impairment of glycemic or lipid metabolism. |
1995 |
Transplant. Proc. |
pmid:8539872
|
Watanabe K et al. |
Fate of long-surviving allografts in tolerant recipients induced by fractionated lymphoid irradiation, donor bone marrow cell infusion, and FK 506 after retransplantation in dogs. |
1993 |
Transplant. Proc. |
pmid:7679813
|
Ryu S and Yasunami Y |
Prevention of immune rejection in rat islet allografts by continuous SC administration of FK 506 using a mini-osmotic pump. |
1991 |
Transplant. Proc. |
pmid:1703710
|
Thomson AW |
Interspecies comparison of the immunosuppressive efficacy and safety of FK 506. |
1990 |
Transplant. Proc. |
pmid:1689883
|
Urbizu JM et al. |
Immunosuppression using tacrolimus/mycophenolate versus neoral/mycophenolate following kidney transplantation: a single-center experience. |
2002 |
Transplant. Proc. |
pmid:11959197
|
Havrdova T et al. |
Effect of tacrolimus versus cyclosporine on glucose metabolism of pancreas and kidney recipients in the late (> 8 years) posttransplant period. |
2011 |
Transplant. Proc. |
pmid:22099774
|
Guitard J et al. |
Hepatitis C virus viral load after conversion from tacrolimus to cyclosporine in liver transplant patients: a pilot study. |
2007 |
Transplant. Proc. |
pmid:17954189
|
Shapiro R et al. |
Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9636557
|
Gavela MartÃnez E et al. |
Use of basiliximab induction in low-immunological risk renal transplant recipients receiving tacrolimus-based immunosuppression. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715913
|
Ochiai M et al. |
Islet toxicity of FK506 measured in canine autografts. |
1998 |
Transplant. Proc. |
pmid:9532224
|
Rodrigo E et al. |
High initial blood levels of tacrolimus in overweight renal transplant recipients. |
2005 |
Transplant. Proc. |
pmid:15866635
|
Fung J et al. |
Randomized trial in primary liver transplantation under immunosuppression with FK 506 or cyclosporine. |
1993 |
Transplant. Proc. |
pmid:7680146
|
MartÃnez-Castelao A et al. |
Arterial elasticity measurement in renal transplant patients under anticalcineurin immunosuppression. |
2005 |
Transplant. Proc. |
pmid:16386539
|
Christians U et al. |
Interactions of FK 506 and cyclosporine metabolism. |
1991 |
Transplant. Proc. |
pmid:1721280
|
Andereggen E et al. |
Immunohistological study of islet xenograft rejection in immunosuppressed recipients. |
1996 |
Transplant. Proc. |
pmid:8623420
|
Serrano M et al. |
Clinical value of a single determination of intracellular ATP levels in stimulated CD4+ T lymphocytes in pediatric patients with stable liver transplantation. |
2012 |
Transplant. Proc. |
pmid:23146475
|
Bilodeau JF et al. |
Evaluation of tolerability and ability to increase immunosuppression in renal transplant patients converted from mycophenolate mofetil to enteric-coated mycophenolate sodium. |
2009 |
Transplant. Proc. |
pmid:19917367
|
McAlister VC et al. |
Cost of liver transplantation using tacrolimus. |
1998 |
Transplant. Proc. |
pmid:9636611
|
Ohtsuka S et al. |
Effect of splenectomy on hamster-to-rat pancreas xenotransplantation. |
1994 |
Transplant. Proc. |
pmid:7518109
|
Oppenheimer F |
Steroid withdrawal in renal transplant recipients. |
2000 |
Transplant. Proc. |
pmid:10686314
|
Porayko MK et al. |
Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. U.S. Multicenter Liver Study Group. |
1995 |
Transplant. Proc. |
pmid:7533358
|
Tamura A et al. |
Combination effect of tacrolimus and FTY720 in liver transplantation in rats. |
1999 |
Transplant. Proc. |
pmid:10578290
|
Wang SC et al. |
FK 506, rapamycin, and cyclosporine: effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line. |
1991 |
Transplant. Proc. |
pmid:1721312
|
Iga C et al. |
Prolonged survival of small intestinal allograft in the rat with cyclosporine A, FK 506, and 15-deoxyspergualin. |
1990 |
Transplant. Proc. |
pmid:1697118
|
Marente VC et al. |
Modigraf administration through jejunostomy in liver transplant recipient: case report. |
2013 |
Transplant. Proc. |
pmid:24314992
|
Malireddy SR et al. |
Altered first-pass effects in a liver transplant recipient explained intraindividual variation in calcineurin inhibitor concentrations: a case report. |
2008 |
Transplant. Proc. |
pmid:18589198
|
Weimer R et al. |
sCD30 and neopterin as risk factors of chronic renal transplant rejection: impact of cyclosporine A, tacrolimus, and mycophenolate mofetil. |
2005 |
Transplant. Proc. |
pmid:15919463
|
Cicero A and Lappin JA |
Pancreas transplantation: experience at University of Texas, Houston. |
2010 Jan-Feb |
Transplant. Proc. |
pmid:20172339
|
EscartÃn A et al. |
Analysis of pig-MAP after small bowel transplantation in pigs. |
1998 |
Transplant. Proc. |
pmid:9865377
|
Malaise J et al. |
Immunosuppressive drugs after simultaneous pancreas-kidney transplantation. |
2005 Jul-Aug |
Transplant. Proc. |
pmid:16182827
|
Zhu Y et al. |
Prolongation of canine renal allograft survival by combining tacrolimus with antimetabolic agents. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123011
|
De Paolis P et al. |
"Immuknow" to measurement of cell-mediated immunity in renal transplant recipients undergoing short-term evaluation. |
2011 |
Transplant. Proc. |
pmid:21620039
|
Platz KP et al. |
Immunosuppressive power and limitations of FK 506 for prevention and treatment of graft-vs-host disease after small bowel transplantation. |
1996 |
Transplant. Proc. |
pmid:8907933
|
Zmonarski SC et al. |
Lowering of Messenger Ribonucleic Acid Toll-Like Receptors 2-4,9 in Peripheral Blood Mononuclear Cells in Kidney Allograft Recipients, Relationships With Immunosuppressive Treatment, and Delayed Graft Function Occurrence. |
2016 |
Transplant. Proc. |
pmid:27496439
|
Imanishi M et al. |
Induction of tolerance by intrathymic injection of donor bone marrow cells in the rat: simultaneous heart and skin allograft model. |
1994 |
Transplant. Proc. |
pmid:7520615
|
Lieberman KV et al. |
FK 506 is a direct glomeruloconstrictor, as determined by electrical resistance pulse sizing (ERPS). |
1991 |
Transplant. Proc. |
pmid:1721376
|
Demetris AJ et al. |
Histopathology of human renal allograft rejection under FK 506: a comparison with cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1703360
|
Stratta RJ |
Optimal immunosuppression in pancreas transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083263
|
Han DJ et al. |
A 39-month follow-up study to evaluate the safety and efficacy in kidney transplant recipients treated with modified-release tacrolimus (FK506E)-based immunosuppression regimen. |
2012 |
Transplant. Proc. |
pmid:22310592
|
Walgenbach KJ et al. |
Immunocytes of composite tissue allografts express elevated levels of TGF beta mRNA and protein during chronic rejection. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123418
|
Chen YB et al. |
Suitable calcineurin inhibitor concentrations for liver transplant recipients in the Chinese population. |
2011 |
Transplant. Proc. |
pmid:21693271
|
Platz KP et al. |
Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients. |
1996 |
Transplant. Proc. |
pmid:8962235
|
Shinozuka H et al. |
Effect of FK 506 on experimental liver carcinogenesis. |
1991 |
Transplant. Proc. |
pmid:1721407
|
Cai X et al. |
Low-dose of FK 506 and associated blood levels in allotransplantation of rat liver, heart, and skin. |
1992 |
Transplant. Proc. |
pmid:1379759
|
Langrehr JM et al. |
Quadruple versus dual tacrolimus-based induction after liver transplantation: a prospective, randomized trial. |
2001 |
Transplant. Proc. |
pmid:11377549
|
Maass E et al. |
Decrease in serum tacrolimus level and rise in serum creatinine under late addition of cinacalcet in a renal transplant recipient with hyperparathyroidism: a case report. |
2007 |
Transplant. Proc. |
pmid:18089410
|
Uber PA et al. |
Steroid weaning in heart transplantation is associated with decreased B-type natriuretic peptide: surrogate evidence for cardiac adaptation. |
2002 |
Transplant. Proc. |
pmid:12176598
|
Vincenti F |
Tacrolimus (FK 506) in kidney transplantation: five-year survival results of the U.S. multicenter, randomized, comparative trial. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267172
|
Tahir W et al. |
Diffuse Alveolar haemorrhage: a fatal complication after alemtuzumab induction therapy in renal transplantation. |
|
Transplant. Proc. |
pmid:25645795
|
Lagget M et al. |
Disappearance of diabetes mellitus after conversion from FK 506 to Neoral in two liver transplanted patients. |
1998 |
Transplant. Proc. |
pmid:9723312
|
Kovarik JM et al. |
Differential pharmacokinetic interaction of tacrolimus and cyclosporine on everolimus. |
2006 |
Transplant. Proc. |
pmid:17175302
|
Moura Neto A et al. |
Clinical Profile of Patients With Diabetes Mellitus and Liver Transplantation: Results After a Multidisciplinary Team Intervention. |
2018 |
Transplant. Proc. |
pmid:29661438
|
Ghio L et al. |
Conversion from tacrolimus to cyclosporine for a non-dose-dependent tacrolimus-induced toxicity, a pediatric kidney transplant recipient case report. |
2004 |
Transplant. Proc. |
pmid:15251325
|
Markus BH et al. |
Daclizumab induction therapy in combination with tacrolimus. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267354
|
Chamienia A et al. |
Open prospective study to evaluate cardiovascular risk factors and renal function in 2 dosage regimens of tacrolimus combined with mycophenolate mofetil and steroids in renal transplant patients: 5-year results. |
2014 |
Transplant. Proc. |
pmid:25380901
|
González MG et al. |
Comparison of post-liver transplantation electrocardiographic alterations between cyclosporine- and tacrolimus-treated patients. |
1999 |
Transplant. Proc. |
pmid:10500652
|
Abe T et al. |
Risk factors for development of new-onset diabetes mellitus and progressive impairment of glucose metabolism after living-donor liver transplantation. |
2014 |
Transplant. Proc. |
pmid:24767367
|
Starzl TE et al. |
Notes on FK 506. |
1991 |
Transplant. Proc. |
pmid:1714647
|
Badiou S et al. |
Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications? |
2006 |
Transplant. Proc. |
pmid:16980076
|